ArticleJournal of comparative effectiveness research2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Talha Munir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.